(Japanese)
(Japanese)
(Japanese)
 |  |  |  |
|---|
Dramatically
Accelerating
Infectious Disease Research.
Our MPV* and Mylc** cells, produced with regenerative medicine technologies, will solve the shortage of experimental cells for researches on malaria and other infectious diseases, and help researchers accelerate their experiments exponentially.
* We are now providing test
and pilot products and will
start full-scale production in 2020.
** We start to sell this product from 12th Dec in 2019.
NEWS RELEASE
Aug 19 ,2020
Aug 19 ,2020
MiCAN will support as a sponsor in JITMM Virtual 2020.
June 16 ,2020
We'll present the functional analysis of myeloid linage cell (Mylc cell) at poster session III in ISSCR 2020.
PRODUCT Video
PRODUCT LINE-UP
Mpv
immature
red blood-like cells for
Malaria (P.vivax)
research
Mylc
special
myeloid lineage cells for
Dengue and other infectious diseases
